FDA Approves SKYTROFA® (Lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency

来源: Nasdaq GlobeNewswire / 28 7月 2025 04:00:00   America/Los_Angeles